Literature DB >> 10634997

What is the blood-brain barrier? A molecular perspective. Cerebral vascular biology.

L R Drewes1.   

Abstract

The term "blood-brain barrier" was coined over one hundred years ago as a result of the observation that vital dyes introduced into the circulation quickly penetrated and stained nearly all organs and tissues of the mammalian body except the brain which retained its pale creamy appearance. Advances in microscopy revealed that, in contrast to other vascular beds, the brain endothelial cells lining the vascular wall are tightly linked with junctional complexes that eliminate gaps or spaces between cells and prevent any free diffusion of blood-borne substances into the brain parenchymal space. The endothelial cells, situated at the interface between blood and brain, therefore, play a critical role in performing essential biological functions including transport of micro- and macronutrients, receptor-mediated signaling, leukocyte trafficking, and osmoregulation. A number of molecular components responsible for some of these unique properties have now been identified and are being characterized under physiological and disease conditions. These include the proteins involved in formation and assembly of tight junctions; the plasma membrane-embedded proteins that are responsible for transport of brain energy substrates and nutrients (glucose, monocarboxylic acids, nucleosides, amino acids, others); the multi-drug transporter protein, p-glycoprotein, and other drug-rejecting proteins that protect the brain from foreign, potentially disruptive chemicals. These and other recent findings, taken as a whole, reveal the brain endothelium as a complex and dynamic biological system, in contrast to the simple, inert and rigid barrier initially perceived.

Entities:  

Mesh:

Year:  1999        PMID: 10634997     DOI: 10.1007/978-1-4615-4711-2_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

3.  Monocytes form a vascular barrier and participate in vessel repair after brain injury.

Authors:  John Glod; David Kobiler; Martha Noel; Rajeth Koneru; Shoshana Lehrer; Daniel Medina; Dragan Maric; Howard A Fine
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

Review 4.  Brain metastases: biology and the role of the brain microenvironment.

Authors:  V K Puduvalli
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

Review 5.  Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.

Authors:  Philip H Elsinga; N Harry Hendrikse; Joost Bart; Aren van Waarde; Willem Vaalburg
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

Review 6.  Melanocortins, Melanocortin Receptors and Multiple Sclerosis.

Authors:  Robert P Lisak; Joyce A Benjamins
Journal:  Brain Sci       Date:  2017-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.